Factor VIII Dosage

Loading...

%
%

References

  1. Suely M Rezende. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology.. Journal of thrombosis and haemostasis : JTH, 2024
  2. Lynn Malec. Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A.. The New England journal of medicine, 2024
  3. I. van Moort. Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial.. The Lancet. Haematology, 2021
  4. R. Klamroth. Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: Results from the phase 3 PROPEL study.. Blood, 2020
  5. G. Young. Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Children with Severe Hemophilia a. Blood, 2016
  6. A. P. Kidwell. Dosing Factor in Pediatric and Adult Hemophilia Patients Using Ideal Body Weight Versus actual Body Weight. Blood, 2016
  7. J. Mahlangu. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.. Blood, 2014
  8. S. Henrard. Impact of being underweight or overweight on factor VIII dosing in hemophilia A patients. Haematologica, 2013
  9. Reference - 10.1056/NEJMoa2209226